| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.34 | 1e-08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.29 | 4e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |